7β-amino-3-methyl-ceph-3-em-4-carboxylic acid diphenylmethyl ester | 35609-70-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 7β-amino-3-methyl-ceph-3-em-4-carboxylic acid diphenylmethyl ester
• 英文别名: 7-amino-3-methyl-3-cephem-4-carboxylic acid benzhydryl ester；(6R)-7t-amino-3-methyl-8-oxo-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester；benzhydryl 7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate；7-Amino-2-benzhydryloxycarbonyl-3-methyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene
• CAS: 35609-70-2
• 化学式: C₂₁H₂₀N₂O₃S
• 分子量: 380.467
• InChiKey: RHOCAKCKESHZJJ-UHFFFAOYSA-N

物化性质

• 沸点：
  590.5±50.0 °C(Predicted)
• 密度：
  1.36±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  27
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  97.9
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-(2-tritylamino-thiazol-4-yl)-(Z)-2-methoxyiminoacetic acid 、 7β-amino-3-methyl-ceph-3-em-4-carboxylic acid diphenylmethyl ester 在 盐酸 、 水 、 magnesium sulfate 、 silica gel 、 乙酸乙酯 、 环己烷 、 mixture 作用下， 以 二氯甲烷 为溶剂， 8.0~40.0 ℃ 、355.5 kPa 条件下， 反应 1.25h， 以2-benzhydryloxycarbonyl-7-[2-methoxyimino-2-(2-tritylamino-thiazol-4yl)-acetamido]-3-methyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene, syn isomer (2.8 g) is obtained in the form of a pale yellow solid的产率得到2-Benzhydryloxycarbonyl-7-[2-methoxyimino-2-(2-tritylamino-thiazol-4-yl)-acetamido]-3-methyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene
  参考文献：
  名称：

  Cephalosporin derivatives

  摘要：

  公式为：##STR1##的新头孢菌素，其中n=0或1，R.sub.1是公式的基团：##STR2## [其中R.sub.4是保护基团，R.sub.5是氢，烷基，乙烯基，氰甲基或保护基团]，或R.sub.1是保护基团，R.sub.2是保护基团或酶可去除的基团，或R.sub.1是酰基基团，可以以不同的方式被取代，R.sub.2是保护基团，如果n=0，则为3-氧乙基-双环辛-2-烯或-双环辛-3-烯或3-氧乙基亚双环辛烷形式，如果n=1，则为3-氧乙基-双环辛-2-烯或3-氧乙基亚双环辛烷形式，可用作制备3-硫基乙烯基头孢菌素的中间体，用作抗菌剂。

  公开号：

  US04365062A1

文献信息

• [EN] NOVEL CEPHALOSPORIN COMPOUNDS AND PROCESS FOR PREPARING THE SAME<br/>[FR] NOUVEAUX COMPOSES A BASE DE CEPHALOSPORINE ET PROCEDE DE FABRICATION CORRESPONDANT
  申请人：LG LIFE SCIENCES LTD

  公开号：WO2003072582A1

  公开（公告）日：2003-09-04

  The present invention relates to a novel cephalosporin compound, and pharmaceutically acceptable non-toxic salt, physiologically hydrolysable ester, hydrate, solvate or isomer thereof, to a pharmaceutical composition comprising the compound, and to a process for preparing the compound.

  本发明涉及一种新的头孢菌素化合物，以及其药用可接受的无毒盐、生理可水解酯、水合物、溶剂合物或异构体，还涉及包含该化合物的药物组合物，以及制备该化合物的方法。
• Cephem compounds
  申请人：Yamanouchi Pharmaceutical Co., Ltd.

  公开号：US04608373A1

  公开（公告）日：1986-08-26

  Novel cephem compounds are provided having the formula: ##STR1## wherein R represents lower alkyl, which may be substituted with lower acyloxy, lower alkylthio or certain 5 or 6-membered heterocyclic ring-containing groups. The cephem compounds and salts thereof exhibit antibacterial activity to many pathogens. A process for producing the cephem compounds is also provided.

  提供具有以下式子的新型头孢菌素化合物：##STR1## 其中，R代表低烷基，该低烷基可以被低酰氧基，低烷基硫基或含有5个或6个成员的杂环环的特定基团所取代。头孢菌素化合物及其盐对许多病原体表现出抗菌活性。还提供了一种生产头孢菌素化合物的方法。
• Novel cephalosporin compounds and process for preparing the same
  申请人：Lee Chang-Seok

  公开号：US20050267092A1

  公开（公告）日：2005-12-01

  The present invention relates to a novel cephalosporin compound, and pharmaceutically acceptable non-toxic salt, physiologically hydrolysable ester, hydrate, solvate or isomer thereof, to a pharmaceutical composition comprising the compound, and to a process for preparing the compound.

  本发明涉及一种新的头孢菌素化合物，以及其药学上可接受的非毒性盐、生理可水解酯、水合物、溶剂化物或异构体，以及包含该化合物的制药组合物，以及制备该化合物的方法。
• 3-Thiovinyl-cephalosporins
  申请人：Rhone-Poulenc Industries

  公开号：US04307116A1

  公开（公告）日：1981-12-22

  Novel cephalosporins of the general formula (I); ##STR1## in which R is alkyl, L-2-amino-2-carboxy-ethyl, phenyl, pyridyl, pyridyl-N-oxide, pyrimidin-2-yl, substituted pyridazin-3-yl, 5,6-dioxo-1,4,5,6-tetrahydro-1,2,4-triazin-3-yl substituted in the 4-position, 1,3,4-triazol-5-yl or 2-alkoxycarbonyl-1,3,4-triazol-5-yl substituted in the 1-position, 1,4-dialkyl-5,6-dioxo-1,4,5,6-tetrahydro-1,2,4-triazin-3-yl, 1-alkyl-5,6-dioxo-1,4,5,6-tetrahydro-1,2,4-triazin-3-yl, 2-alkyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl, triazol-5-yl, 1,3,4-thiadiazol-5-yl which is substituted or unsubstituted, 1,2,4-thiadiazol-5-yl which is substituted, 1,3,4-oxadiazol-5-yl which is substituted or unsubstituted, oxazol-2-yl which is substituted or unsubstituted or tetrazol-5-yl which is substituted or unsubstituted in the 1-position, R' is a hydrogen atom or a radical of the general formula (II); ##STR2## and R.sup.o is hydrogen, alkyl, vinyl or cyanomethyl, as well as their salts, are useful as anti-bacterial agents.

  通式(I)的新型头孢菌素；其中R为烷基，L-2-氨基-2-羧基乙基，苯基，吡啶基，吡啶-N-氧化物，嘧啶-2-基，取代的吡啶-3-基，4-位取代的5,6-二氧化-1,4,5,6-四氢-1,2,4-三嗪-3-基，1,3,4-三唑-5-基或1-位取代的2-烷氧羰基-1,3,4-三唑-5-基，1,4-二烷基-5,6-二氧化-1,4,5,6-四氢-1,2,4-三嗪-3-基，1-烷基-5,6-二氧化-1,4,5,6-四氢-1,2,4-三嗪-3-基，2-烷基-5,6-二氧化-1,2,5,6-四氢-1,2,4-三嗪-3-基，三唑-5-基，1,3,4-噻二唑-5-基，取代或未取代的1,2,4-噻二唑-5-基，取代或未取代的1,3,4-噁二唑-5-基，取代或未取代的噁唑-2-基或取代或未取代的1-位四唑-5-基，R'为氢原子或通式(II)的基团；其中R.sup.o为氢，烷基，乙烯基或氰甲基，以及它们的盐，可用作抗菌剂。
• 3-Vinyl-cephalosporins
  申请人：Rhone-Poulenc Industries

  公开号：US04307230A1

  公开（公告）日：1981-12-22

  Novel 3-vinyl-cephalosporins of the formula ##STR1## in which n is 0 or 1, R.sub.1 is hydrogen, a radical of the formula ##STR2## [in which R.sub.4 is hydrogen or a protective radical and R.sub.5 is hydrogen, alkyl, vinyl or cyanomethyl or is a protective radical], or a protective radical, and R.sub.2 is hydrogen, a protective radical or an enzymatically removable radical, or R.sub.1 is hydrogen or an acyl radical which may carry various substituents and R.sub.2 is hydrogen or a protective radical, and R.sub.3 is a radical of the general formula R'.sub.3 --SO.sub.2 --O-- or R".sub.3 --CO--O--, in which R'.sub.3 is alkyl, trifluoromethyl, trichloromethyl or phenyl which is substituted by a halogen atom or by an alkyl or nitro radical, and R".sub.3 is defined like R'.sub.3 or represents methyl which is substituted by acyl or alkoxycarbonyl, or represents ethyl or propyl substituted in the 2-position by acyl or alkoxycarbonyl. These compounds are useful as intermediates for the preparation of antibiotic 3-thiovinyl-cephalosporins.

  式为##STR1##的新型3-乙烯基头孢菌素，其中n为0或1，R.sub.1为氢，式为##STR2##的基团[其中R.sub.4为氢或保护基团，R.sub.5为氢、烷基、乙烯基或氰甲基或为保护基团]，或保护基团，R.sub.2为氢、保护基团或酶可去除的基团，或R.sub.1为氢或可携带各种取代基的酰基基团，R.sub.2为氢或保护基团，R.sub.3为一般式R'.sub.3--SO.sub.2--O--或R".sub.3--CO--O--的基团，其中R'.sub.3为烷基、三氟甲基、三氯甲基或被卤素原子、烷基或硝基基团取代的苯基，R".sub.3的定义与R'.sub.3相同或代表被酰基或烷氧羰基取代的甲基，或代表2-位被酰基或烷氧羰基取代的乙基或丙基。这些化合物可用作制备抗生素3-硫代乙烯基头孢菌素的中间体。